October 8, 2018 Dataset Open Access

Harding, Rachel; Lemak, Sasha; Arrowsmith, Cheryl

BibTeX Export

@dataset{harding_rachel_2018_2207216,
  author       = {Harding, Rachel and
                  Lemak, Sasha and
                  Arrowsmith, Cheryl},
  title        = {{SAXS data collection and analysis of Q23 HTT and 
                   HTT-HAP40 samples - 2018/10/08}},
  month        = oct,
  year         = 2018,
  note         = {{Dr. Harding is the recipient of the Huntington's 
                   Disease Society of America Berman Topper Career
                   Development Fellowship which funds and supports
                   this research. Dr. Harding's research is also
                   supported with generous funding from the
                   Huntington Society of Canada and the CHDI
                   Foundation. The SGC is a registered charity
                   (number 1097737) that receives funds from AbbVie,
                   Bayer Pharma AG, Boehringer Ingelheim, Canada
                   Foundation for Innovation, Eshelman Institute for
                   Innovation, Genome Canada through Ontario Genomics
                   Institute [OGI-055], Innovative Medicines
                   Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766],
                   Janssen, Merck KGaA, Darmstadt, Germany, MSD,
                   Novartis Pharma AG, Ontario Ministry of Research,
                   Innovation and Science (MRIS), Pfizer, São Paulo
                   Research Foundation-FAPESP, Takeda, and Wellcome.}},
  publisher    = {Zenodo},
  doi          = {10.5281/zenodo.2207216},
  url          = {https://doi.org/10.5281/zenodo.2207216}
}